Aspiration therapy for obesity; a safe and effective treatment

• DOI: 10.1186/s40608-016-0134-0
• Publication Date: 2016-12-28T05:47:41Z
• Authors: Erik Norén; Henrik Forssell
• Keywords: 2. Zero hunger; 03 medical and health sciences; 0302 clinical medicine; Research Article; 3. Good health

This study evaluated the efficacy and safety of novel AspireAssist® Aspiration Therapy System for treatment obesity, its effect on patient's quality life.A prospective observational with 25 obese subjects, mean age 48 years (range 33-65), was performed. A custom gastrostomy tube (A-tube, Aspire Bariatrics) percutaneously inserted during a gastroscopy performed under conscious sedation. Drainage irrigation stomach were 3 times daily, 20 min after each meal, 1-2 years. Efficient aspiration required thorough chewing ingested food. Treatment included cognitive behavioral weight loss program.Mean body mass index (BMI) at inclusion 39.8 kg/m2 35-49). After 1 year (SD) BMI 32.1 (5.4), p < 0.01, excess 54.4% (28.8), 0.01. Quality life, as measured EQ-5D, improved from 0.73 (0.27) to 0.88 (0.13), 2 31.0 (5.1), 61.5% (28.5), There no serious adverse events or electrolyte disorders. Compliance 80% 60% years.Aspiration therapy is an efficient safe reduction improves life. Excess approximately halved in year, stability if continued.Trial Register ISRCTN 49958132. Retrospectively registered 28/02/2014.